s6y Tvardi Therapeutics, Inc. EFFECT

Tvardi Therapeutics, Inc. EFFECT, filed May 13, 2026: primary_doc.xml

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: May 13, 2026
Accession Number: 0001104659-26-057914
Submission Type: POS AM
CIK: 0001346830
Company Name: Tvardi Therapeutics, Inc.
File Number: 333-287675